BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27816686)

  • 1. In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line.
    Zhen S; Lu JJ; Wang LJ; Sun XM; Zhang JQ; Li X; Luo WJ; Zhao L
    Transl Oncol; 2016 Dec; 9(6):498-504. PubMed ID: 27816686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
    Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
    Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Targeting of HPV18 E6 and E7 Synchronously by Nonviral Transfection of CRISPR/Cas9 System in Cervical Cancer.
    Ling K; Yang L; Yang N; Chen M; Wang Y; Liang S; Li Y; Jiang L; Yan P; Liang Z
    Hum Gene Ther; 2020 Mar; 31(5-6):297-308. PubMed ID: 31989837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9.
    Zhen S; Hua L; Takahashi Y; Narita S; Liu YH; Li Y
    Biochem Biophys Res Commun; 2014 Aug; 450(4):1422-6. PubMed ID: 25044113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus Oncogene Manipulation Using Clustered Regularly Interspersed Short Palindromic Repeats/Cas9 Delivered by pH-Sensitive Cationic Liposomes.
    Zhen S; Liu Y; Lu J; Tuo X; Yang X; Chen H; Chen W; Li X
    Hum Gene Ther; 2020 Mar; 31(5-6):309-324. PubMed ID: 31973584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells.
    Hu Z; Yu L; Zhu D; Ding W; Wang X; Zhang C; Wang L; Jiang X; Shen H; He D; Li K; Xi L; Ma D; Wang H
    Biomed Res Int; 2014; 2014():612823. PubMed ID: 25136604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking activity of the HPV18 virus in cervical cancer cells using the CRISPR/Cas9 system.
    Wang J; Guo M; Wang Q; Dang J; Liu X; Jin Z
    Int J Clin Exp Pathol; 2018; 11(8):4230-4235. PubMed ID: 31949818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells.
    Ehrke-Schulz E; Heinemann S; Schulte L; Schiwon M; Ehrhardt A
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells.
    Yu L; Wang X; Zhu D; Ding W; Wang L; Zhang C; Jiang X; Shen H; Liao S; Ma D; Hu Z; Wang H
    Onco Targets Ther; 2015; 8():37-44. PubMed ID: 25565864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6.
    Yoshiba T; Saga Y; Urabe M; Uchibori R; Matsubara S; Fujiwara H; Mizukami H
    Oncol Lett; 2019 Feb; 17(2):2197-2206. PubMed ID: 30675284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer.
    Zhen S; Li X
    Cell Physiol Biochem; 2017; 44(6):2455-2466. PubMed ID: 29268281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
    Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
    Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-mediated knockout of MLL5 enhances apoptotic effect of cisplatin in HeLa cells
    Pirouzfar M; Amiri F; Dianatpour M; Takhshid MA
    EXCLI J; 2020; 19():170-182. PubMed ID: 32194363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic delivery of specific and efficient CRISPR/Cas9 system targeting HPV16 oncogenes using LL-37 antimicrobial peptide in C57BL/6 mice.
    Khairkhah N; Bolhassani A; Rajaei F; Najafipour R
    J Med Virol; 2023 Jul; 95(7):e28934. PubMed ID: 37403986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbranched poly(β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer.
    Gao X; Jin Z; Tan X; Zhang C; Zou C; Zhang W; Ding J; Das BC; Severinov K; Hitzeroth II; Debata PR; He D; Ma X; Tian X; Gao Q; Wu J; Tian R; Cui Z; Fan W; Huang Z; Cao C; Bao Y; Tan S; Hu Z
    J Control Release; 2020 May; 321():654-668. PubMed ID: 32114092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of CRISPR/Cas9 system in cervical carcinogenesis.
    Gao C; Wu P; Yu L; Liu L; Liu H; Tan X; Wang L; Huang X; Wang H
    Cancer Gene Ther; 2022 May; 29(5):466-474. PubMed ID: 34349239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
    Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
    Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.